FDA Inspection 1111054 — Qilu Pharmaceutical (Hainan) Co. Ltd.
The FDA completed an inspection of Qilu Pharmaceutical (Hainan) Co. Ltd. on November 6, 2019 in Haikou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 6, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Haikou (China)